Aptus Capital Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Sell
8,518
-5,487
-39% -$255K ﹤0.01% 775
2025
Q4
$610K Buy
14,005
+475
+4% +$21.7K ﹤0.01% 688
2025
Q3
$609K Buy
13,530
+749
+6% +$32.9K ﹤0.01% 657
2025
Q2
$555K Sell
12,781
-3,725
-23% -$166K ﹤0.01% 656
2025
Q1
$761K Buy
16,506
+2,140
+15% +$89.5K 0.01% 556
2024
Q4
$541K Buy
14,366
+4,049
+39% +$157K 0.01% 612
2024
Q3
$418K Buy
10,317
+905
+10% +$34K 0.01% 586
2024
Q2
$326K Buy
9,412
+304
+3% +$11.2K 0.01% 599
2024
Q1
$342K Buy
9,108
+3,330
+58% +$119K 0.01% 598
2023
Q4
$207K Sell
5,778
-703
-11% -$27.1K 0.01% 550
2023
Q3
$245K Buy
+6,481
New +$264K 0.01% 517

Other funds holding EXC

Aptus Capital Advisors's EXC Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Exelon (EXC) stake by 39% in Q1 2026, selling an estimated $255K and leaving 8,518 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

Aptus Capital Advisors first reported a position in EXC in Q3 2023 and has held it in 11 quarters since. The position peaked at $761K in Q1 2025. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Aptus Capital Advisors held 8,518 shares of Exelon worth $418K as of Q1 2026.
  • Aptus Capital Advisors sold 5,487 Exelon shares in Q1 2026, an estimated $255K.
  • Exelon made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q1 2026, its #775 holding.
  • Aptus Capital Advisors first reported a position in Exelon in Q3 2023 and has held it in 11 quarters since.
  • Aptus Capital Advisors's Exelon position peaked at $761K in Q1 2025.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.